Port - yes, the full results were expected by the end of April 2009 (according to the release on 11 Aug 2008) so I don't know why management are sitting on their hands. Dosing was to be completed Dec 2008/ Jan 2009 but 'subject to adequate enrolment rates with volunteers', so they might have had a delay on this front. In Wilson's latest report they seem to highlight that several announcements will take place between June to August 2009 and HRV is one of those announcements - I don't know whether that's pure speculation on their part or have spoken to management about it. I guess we're only 4 weeks overdue and don't see that as a long time in the Biotech world.
BTA Price at posting:
$1.38 Sentiment: Buy Disclosure: Held